IPAM Trademark

Trademark Overview


On Tuesday, April 12, 2022, a trademark application was filed for IPAM with the United States Patent and Trademark Office. The USPTO has given the IPAM trademark a serial number of 97359213. The federal status of this trademark filing is REGISTERED as of Tuesday, August 6, 2024. This trademark is owned by imnewrun Biosciences, Inc.. The IPAM trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Reagents for use in medical genetic testing; Preparations for detecting mutation in prion genes for medical purposes; Diagnostic preparations for medical purposes for detecting presence of mutation in prion genes; medicines for human purposes for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Pharmaceutical preparations for health care; Vaccines; Diagnostic reagents for medical use; Cultures of Microorganisms for medical purposes; Biotechnological preparations in the nature of enzymes for medical purposes; Stem cell...

Medical and health assessment services relating to DNA, genetics and genetic testing; Genetic testing for medical treatment purposes; Provision of genetic testing for medical treatment purposes; Provision of Genetic information for medical treatment purposes; Providing gene therapy for medical treatment purposes; Genetic counseling for medical purposes; Medical diagnostic testing, monitoring and reporting services; DNA analysis for medical purposes; DNA screening for medical purposes

Scientific research in the fields of biomedicine; Pharmaceutical drug development services; Research and development of technology for medicinal chemical manufacturing; scientific research in the nature of evaluating clinical trials
ipam

General Information


Serial Number97359213
Word MarkIPAM
Filing DateTuesday, April 12, 2022
Status700 - REGISTERED
Status DateTuesday, August 6, 2024
Registration Number7464893
Registration DateTuesday, August 6, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements


Goods and ServicesPharmaceuticals for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Reagents for use in medical genetic testing; Preparations for detecting mutation in prion genes for medical purposes; Diagnostic preparations for medical purposes for detecting presence of mutation in prion genes; medicines for human purposes for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Pharmaceutical preparations for health care; Vaccines; Diagnostic reagents for medical use; Cultures of Microorganisms for medical purposes; Biotechnological preparations in the nature of enzymes for medical purposes; Stem cells for medical purposes; Enzymes for medical purposes; Nucleic acid sequences for medical and veterinary purposes
Goods and ServicesMedical and health assessment services relating to DNA, genetics and genetic testing; Genetic testing for medical treatment purposes; Provision of genetic testing for medical treatment purposes; Provision of Genetic information for medical treatment purposes; Providing gene therapy for medical treatment purposes; Genetic counseling for medical purposes; Medical diagnostic testing, monitoring and reporting services; DNA analysis for medical purposes; DNA screening for medical purposes
Goods and ServicesScientific research in the fields of biomedicine; Pharmaceutical drug development services; Research and development of technology for medicinal chemical manufacturing; scientific research in the nature of evaluating clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 18, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 18, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIMNEWRUN, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSUWON-SI, GYEONGGI-DO 16419
KR

Party NameIMNEWRUN, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSUWON-SI, GYEONGGI-DO 16419
KR

Party NameIMNEWRUN, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSUWON-SI, GYEONGGI-DO
KR

Party Nameimnewrun Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGyeonggi-do, 16419
KR

Trademark Events


Event DateEvent Description
Friday, April 15, 2022NEW APPLICATION ENTERED
Monday, April 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 29, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, May 5, 2022ASSIGNED TO LIE
Thursday, May 5, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, May 9, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, May 10, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, June 29, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, January 13, 2023ASSIGNED TO EXAMINER
Friday, January 13, 2023NON-FINAL ACTION WRITTEN
Friday, April 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 13, 2023NON-FINAL ACTION E-MAILED
Friday, January 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 3, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 23, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 30, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 8, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Friday, January 12, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 12, 2024SOU EXTENSION 1 FILED
Monday, February 5, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, January 30, 2024SOU EXTENSION 1 GRANTED
Wednesday, January 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 5, 2024ASSIGNED TO PETITION STAFF
Tuesday, February 6, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, March 4, 2024NOTICE OF ALLOWANCE CANCELLED
Monday, March 4, 2024CASE RETURNED TO EXAMINATION
Monday, March 18, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, March 18, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, March 18, 2024EXAMINERS AMENDMENT E-MAILED
Monday, March 18, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 18, 2024EXAMINER'S AMENDMENT ENTERED
Monday, April 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 11, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, April 4, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 6, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED